Lalatsa A, Butt AM
This article examines the potential indirect mechanisms through which Wegovy and weight loss may influence sexual health, provides practical management strategies, and clarifies when to seek medical advice
Innovent Biologics Inc
Collagens: molecular biology, diseases, and potentials for therapy
Optic Nerve Damage Associated With GLP-1 Drugs: Troubling Evidence GLP-1 receptor agonists such as Wegovy/Ozempic (semaglutide), Zepbound (tirzepatide) and Saxenda (liraglutide) have been instrumental in addressing diabetes and obesity, yet recent peer-reviewed research reveals troubling evidence linking these drugs to NAION, a condition characterized by reduced blood flow causing sudden vision loss due to optic nerve damage
10, 2025 - 3 minutes Overview: Global sales of GLP-1, a medication used to manage blood sugar levels for those with Type 2 diabetes, is projected to reach US$139 billion by 2030, up 2.6x from sales posted in 2024